Perfluoroalkyl/Polyfluoroalkyl Substances: Links to Cardiovascular Disease Risk.
| Autor: | Schlezinger JJ; Department of Environmental Health, Boston University School of Public Health, Boston, MA (J.J.S.)., Gokce N; Evans Department of Medicine and Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA (N.G.). |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Circulation research [Circ Res] 2024 Apr 26; Vol. 134 (9), pp. 1136-1159. Date of Electronic Publication: 2024 Apr 25. |
| DOI: | 10.1161/CIRCRESAHA.124.323697 |
| Abstrakt: | Conservative estimates by the World Health Organization suggest that at least a quarter of global cardiovascular diseases are attributable to environmental exposures. Associations between air pollution and cardiovascular risk have garnered the most headlines and are strong, but less attention has been paid to other omnipresent toxicants in our ecosystem. Perfluoroalkyl and polyfluoroalkyl substances (PFASs) are man-made chemicals that are extensively used in industrial and consumer products worldwide and in aqueous film-forming foam utilized in firefighting. As such, our exposure to PFAS is essentially ubiquitous. Given the long half-lives of these degradation-resistant chemicals, virtually, all people are carrying a body burden of PFAS. Health concerns related to PFAS are growing such that the National Academies of Sciences, Engineering and Medicine has recommended standards for clinical follow-up of individuals with high PFAS blood levels, including prioritizing screening for dyslipidemia. The link between PFAS and dyslipidemia has been extensively investigated, and evidence for associations is compelling. However, dyslipidemia is not the only cardiovascular risk factor with which PFAS is associated. Here, we review the epidemiological evidence for links between PFAS of concern identified by the National Academies of Sciences, Engineering and Medicine and risk factors for cardiovascular disease, including overweight/obesity, glucose intolerance, hypertension, dyslipidemia, and hyperuricemia. Moreover, we review the potential connections of PFAS with vascular disease and atherosclerosis. While observational data support associations between the National Academies of Sciences, Engineering and Medicine PFAS and selected cardiac risk factors, additional research is needed to establish causation and better understand how exposure to PFAS leads to the development of these conditions. Competing Interests: Disclosures None. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|